ArticleMolecular biology reports2024

Sesamol-mediated targeting of EPHA2 sensitises cervical cancer for cisplatin treatment by regulating mitochondrial dynamics, autophagy, and mitophagy.

P P Mubthasima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.